In this final segment of Market Checkup, the Motley Fool's health-care focused investing show, analyst David Williamson explains why small-cap Cambrex Corporation is on his watchlist.
 
Headquartered right next to Super Bowl site MetLife Stadium, Cambrex is a life sciences company focused on making active pharmaceutical ingredients. Essentially, it makes the drugs the drug companies sell. In many ways Cambrex is almost more of an industrial stock than a health-care stock.
 
In this video, David highlights Cambrex's financial performance, why a mystery client has the rumor mill buzzing, and why investors should watch Cambrex's quaterly results.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.